Tokyo, July 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058372) titled 'Efficacy of immune checkpoint inhibitors in patients with MSI-H/dMMR small bowel adenocarcinoma' on July 7.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Toyohashi Municipal Hospital
Condition:
Condition - MSI-H/dMMR small bowel adenocarcinoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Meta-analysis of the efficacy of immune checkpoint inhibitors in MSI-H/dMMR small bowel adenocarcinoma
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion crit...